FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Deferoxamine Mesylate for Injection (Desferal)
Status: Discontinuation
»Therapeutic Categories: Oncology

Novartis (Revised 09/09/2015)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
2 gm Vial (NDC 0078-0347-51) 09/14/2015 The 2gm strength (NDC 0078-0347-51) vial is to be discontinued as of September 2015. The 500mg strength vial (NDC 0078-0467-91) will continue to be sold.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English